August 30, 2018 / 8:19 PM / a year ago

FDA approves two new HIV drugs from Merck

Aug 30 (Reuters) - Drugmaker Merck & Co Inc said on Thursday the U.S. Food And Drug Administration approved two of its oral medicines to treat HIV patients.

U.S. regulators approved Delstrigo, a once-a-day combination tablet, but added a boxed warning, the agency’s strictest, to flag risk of worsening hepatitis B infection.

Pifeltro, the second approved drug, is an oral medicine to be administered in combination with other antiretroviral medicines, Merck said. (Reporting by Tamara Mathias in Bengaluru; Editing by Sriraj Kalluvila)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below